400 results on '"Woller, Scott C."'
Search Results
2. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
3. Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial
4. DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network
5. Below the knee, let it be: Management of calf DVT in hospitalized trauma patients
6. Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry
7. Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound
8. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
9. The Risk Assessment Profile is suboptimal for guiding duplex ultrasound surveillance in trauma patients
10. Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19
11. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
12. Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network
13. Performance of a Prospective Anticoagulation Stratification Algorithm After Liver Transplantation
14. Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation
15. Post‐discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers
16. Abstract 12122: Five-Year Serial Measurement of the Intermountain Mortality Risk Score for Population Health Assessment Reveals Personalized Temporal Trajectories of Differential Longevity Over Two Decades
17. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta‐analysis
18. Predicting postdischarge hospital‐associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers
19. Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncope
20. Primary Care Clinicians’ Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment
21. ASSOCIATION OF OZONE AND PM2.5 AIR POLLUTION ON SHORT-TERM VENOUS THROMBOEMBOLISM RISK, INCLUDING 10861 VTE EVENTS IN AN INTEGRATED HEALTH SYSTEM: 17 YEARS OF LONGITUDINAL DATA
22. Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM‐DVT): Methods of a prospective single‐arm management study
23. Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment.
24. Excluding pregnancy-associated DVT with whole-leg ultrasound
25. 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report
26. Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals
27. Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: A double-blind, randomized, pilot study
28. Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers
29. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation
30. THROMBOEMBOLISM-RISK-BASED ALGORITHM DECREASES ANTICOAGULATION RATES AND BLEEDING RISK AFTER LIVER TRANSPLANTATION
31. Remote Biometric Monitoring of Patients With COVID-19 With Exertional Hypoxia Treated With Supplemental Oxygen
32. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes
33. Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients
34. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation
35. Follow-up of Incidental Pulmonary Nodules and the Radiology Report
36. DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network
37. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities
38. Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools
39. Synoptic reporting accuracy for computed tomography pulmonary arteriography among patients suspected of pulmonary embolism
40. Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
41. P9.18: Decreasing Therapeutic Anticoagulation and Bleeding in Post-operative Liver Transplant Patients: A Single Institution’s Analysis of a Prospective Anticoagulation Algorithm
42. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
43. A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH
44. Comparative Frequency of Venous Thromboembolism in Patients Admitted to the Hospital with SARS-CoV-2 Infection versus Community-acquired Pneumonia
45. Follow-up of Incidental Pulmonary Nodules and the Radiology Report
46. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
47. Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
48. Adherence to PIOPED II Investigators' Recommendations for Computed Tomography Pulmonary Angiography
49. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial
50. IMPACT OF ANTICOAGULATION THERAPY ON THECOGNITIVE DECLINE AND DEMENTIA IN PATIENTS WITH NON-VALVULARATRIALFIBRILLATION (CAF) TRIAL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.